Investing.com -- According to Nikkei , Fosun Pharmaceutical (TADAWUL: 2070 ) Group, a Chinese drugmaker, has entered into an agreement to sell its ownership stake in a hospital group to Warburg Pincus, a U.S. private equity firm. The deal, valued at $124.08 million, involves a 6.6% stake in New Frontier Health, which is being transferred to a fund managed by Warburg Pincus.

New Frontier Health operates a network of healthcare facilities, including 11 hospitals and 24 clinics, under the United Family Healthcare brand. This transaction allows Fosun Pharma to concentrate its resources on drug development, aligning with its core business operations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.